FAP and neoplasm: The in vivo distribution and metabolic characteristics of [68Ga]Ga-FAP-2286-ICG in U87MG tumor-bearing mice were evaluated in real-time and noninvasively via PET/CT imaging at 30, 60 and 90 min post-injection of the radiotracer.